Synthetic Biologics Inc. (SYN) plunge -16.33% in a week: will this be a lucky break through?

As on February 22, 2021, Synthetic Biologics Inc. (AMEX: SYN) started slowly as it slid -3.51% to $0.83. During the day, the stock rose to $0.89 and sunk to $0.80 before settling in for the price of $0.86 at the close. Taking a more long-term approach, SYN posted a 52-week range of $0.25-$1.70.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Meanwhile, its Annual Earning per share during the time was 38.60%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 75.90%. This publicly-traded company’s shares outstanding now amounts to $19.40 million, simultaneously with a float of $19.38 million. The organization now has a market capitalization sitting at $61.84 million. At the time of writing, stock’s 50-day Moving Average stood at $0.6984, while the 200-day Moving Average is $0.5070.

Synthetic Biologics Inc. (SYN) Ownership Facts and Figures

Another important factor to analyze is how key investors are playing towards the stock of the Biotechnology industry. Synthetic Biologics Inc.’s current insider ownership accounts for 0.37%, in contrast to 2.40% institutional ownership.

Synthetic Biologics Inc. (SYN) Earnings and Revenue Records

If we go through the results of last quarter, which was made public on 9/29/2020, the company posted -$0.14 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -$0.17) by $0.03. This company achieved a return on equity of -69.99. Wall Street market experts anticipate that the next fiscal year will bring earnings of 0 per share during the current fiscal year.

Synthetic Biologics Inc.’s EPS increase for this current 12-month fiscal period is 75.90% and is forecasted to reach -0.27 in the upcoming year.

Synthetic Biologics Inc. (AMEX: SYN) Trading Performance Indicators

Let’s observe the current performance indicators for Synthetic Biologics Inc. (SYN). It’s Quick Ratio in the last reported quarter now stands at 2.20. The Stock has managed to achieve an average true range (ATR) of 0.13.

In the same vein, SYN’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -0.71, a figure that is expected to reach -0.08 in the next quarter, and analysts are predicting that it will be -0.27 at the market close of one year from today.

Technical Analysis of Synthetic Biologics Inc. (SYN)

Through scrutinizing the latest numbers posted by the [Synthetic Biologics Inc., SYN], it can be observed that its last 5-days Average volume of 24.66 million was lower the volume of 29.81 million, it posted the year before. During the previous 9 days, stock’s Stochastic %D was recorded 24.51% While, its Average True Range was 0.1218.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on...

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .

Sponsored


Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Raw Stochastic average of Synthetic Biologics Inc. (SYN) in the period of the previous 100 days is set at 39.72%, which indicates a major rise in contrast to 14.50% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 148.45% that was lower than 167.83% volatility it exhibited in the past 100-days period.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Recent Articles

Intel (INTC) Intends to appeal against Court order for Violation of VLSI Tech

In the last quarter, Intel's (INTC) share price rose 29%. On Tuesday, Intel fell 2.6% after Federal Judge Jim Davis ruled the company must...

The Facts You Need to Know about Itron Inc. (ITRI) Moving Forward

Itron, Inc. (NASDAQ: ITRI) released a positive update for the fourth quarter and full-year 2020. This quarter was highlighted by a record portfolio of...

One stock you can’t skip: Bionano Genomics Inc. [BNGO]

Bionano Genomics Inc. (BNGO) stock prices have grown nearly 1,000% in the past 12 months. Despite this, some analysts feel that the shares have...

What the sentiment indicator is Signaling: CEVA Inc (CEVA)

CEVA, Inc. (NASDAQ: CEVA) reported its fourth-quarter report on Tuesday, February 16; the company signed 21 new agreements generating record revenues. CEVA provides OEMs with...

A Stock Check: Which direction Pinterest Inc (PINS) will move from here?

The social networking company Pinterest Inc (PINS) rose 226% in the past year. If the price has increased significantly, is it worthwhile to acquire...

Related Stories

Leave A Reply

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the Newsheater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.